Stephanie G. Willis

Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)–based mutagenesis screen: high efficacy of drug combinations

Heather A. Bradeen, Christopher A. Eide, Thomas O’Hare et al. · Blood · 2006 · 401 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +8

High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy

Stephanie G. Willis, Thoralf Lange, Shadmehr Demehri et al. · Blood · 2005 · 300 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Phylogenetic and physiological comparisons of PAH-degrading bacteria from geographically diverse soils

James G. Mueller, Richard Devereux, Deborah L. Santavy et al. · Antonie van Leeuwenhoek · 1997 · 192 citations

Life Sciences, Microbiology, Soil Sciences +16

Molecular Phylogenetic and Biogeochemical Studies of Sulfate-Reducing Bacteria in the Rhizosphere of <i>Spartina alterniflora</i>

Mark E. Hines, Robert S. Evans, Barbara R. Sharak Genthner et al. · Applied and Environmental Microbiology · 1999 · 164 citations · Full text

Agriculture, Plant Biology, Plant Sciences +17

High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients

Jeffrey Tyner, Heidi S. Erickson, Michael W. Deininger et al. · Blood · 2008 · 134 citations · Full text

Medicine, Molecular Genetics, Oncology +16